The INVENT COVID trial: a structured protocol for a randomized controlled trial investigating the efficacy and safety of intravenous imatinib mesylate (Impentri®) in subjects with acute respiratory distress syndrome induced by COVID-19

Peer Review reports

Original Submission
1 Jun 2021	Submitted	Original manuscript
19 Jul 2021	Reviewed	Reviewer Report - Muslim Syed
11 Sep 2021	Reviewed	Reviewer Report - Jayesh Dhanani
28 Sep 2021	Author responded	Author comments - Leila Atmowihardjo
Resubmission - Version 2
28 Sep 2021	Submitted	Manuscript version 2
4 Oct 2021	Reviewed	Reviewer Report - Muslim Syed
15 Nov 2021	Author responded	Author comments - Leila Atmowihardjo
Resubmission - Version 3
15 Nov 2021	Submitted	Manuscript version 3
14 Dec 2021	Reviewed	Reviewer Report - Muslim Syed
Resubmission - Version 4
	Submitted	Manuscript version 4
Publishing
27 Jan 2022	Editorially accepted
16 Feb 2022	Article published	10.1186/s13063-022-06055-9

Back to article page